Day: August 26, 2023

FOND DU LAC, Wisc., Aug. 26, 2023 (GLOBE NEWSWIRE) — Mercury Marine and the negotiating committee of the labor union, IAMAW Lodge 1947, have announced a new collective bargaining agreement. The new contract, which will remain in place through September 30, 2028, was voted in favor by the members of the IAMAW Lodge 1947 and will be signed by both Mercury Marine and the IAMAW. Complete details of the agreement will not be made public. “We are pleased to announce that together with our union leadership, we have a ratified contract that has been passed by our union employees.  The new five-year contract is in the best interest of our workforce and the continued growth of Mercury Marine,” said John Buelow, Mercury Marine president.  “This agreement strengthens our partnership for the future and our commitment to being a top employer...

– In total cardiovascular event analysis, bempedoic acid shows 20% risk reduction in MACE-4 and 17% risk reduction in MACE-3 – – In an analysis of patients with diabetes, bempedoic acid shows 17% risk reduction in MACE-4 and 20% risk reduction in MACE-3 – – No increase in development of new onset diabetes in patients randomized to bempedoic acid compared to placebo – ANN ARBOR, Mich., Aug. 26, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the presentation of results from two oral presentations at the Late-Breaking Science Session entitled, “Clinical trial updates on prevention and lipid lowering” at the European Society of Cardiology (ESC) 2023 Congress, taking place August 25-28, 2023, in Amsterdam, Netherlands. “We are pleased to share additional results from our landmark CLEAR Outcomes study in late-breaker...

Following improved business performance in Q2 and H1 2023, NNIT upgrades the full-year outlook and now expects to generate revenue growth of around 15% and an operating profit margin before special items of around 6% in 2023 against the previous expectations for revenue growth around 10% and an operating profit margin before special items of around 5%. Special items are still expected to amount to up to DKK 70 million in 2023. According to preliminary and unaudited financial figures, group revenue grew by 15% to DKK 424 million (2022: DKK 368 million) in Q2 2023 and by 16% to DKK 837 million (2022: DKK 724 million) in H1 2023. The group’s operating profit before special items increased to DKK 25 million (2022: DKK -18 million) in Q2 2023 and DKK 45 million (2022: DKK -34 million) in H1 2023, corresponding to an operating profit margin...

Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,234,280 shares, corresponding to 2,78% ownership. Ferncliff Listed DAI AS is closely associated with board member Øystein Stray Spetalen.Attachment20230825_Notification of trade_Ferncliff i Vistin